Kindred Biosciences (Kindred Biosciences) EV-to-EBITDA : -10.60 (As of May. 06, 2024)

Kindred Biosciences EV-to-EBITDA Chart

Kindred Biosciences Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EV-to-EBITDA		Get a 7-Day Free Trial				-1.27	-5.94	-5.90	-4.72	-8.84

Kindred Biosciences Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
EV-to-EBITDA	Get a 7-Day Free Trial															-5.56	-6.78	-8.84	-95.02	-10.46

Competitive Comparison of Kindred Biosciences's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Kindred Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindred Biosciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kindred Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kindred Biosciences's EV-to-EBITDA falls into.

Kindred Biosciences EV-to-EBITDA Calculation

Kindred Biosciences's EV-to-EBITDA for today is calculated as:

Kindred Biosciences's current Enterprise Value is $369.55 Mil.
Kindred Biosciences's EBITDA for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-34.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kindred Biosciences  (NAS:KIN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kindred Biosciences's PE Ratio for today is calculated as:

Kindred Biosciences's share price for today is $9.25.
Kindred Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.020.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Kindred Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Kindred Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindred Biosciences (Kindred Biosciences) Business Description